Thrombin converts fibrinogen into fibrin, producing a cross-linked network that gives the implant structural stability. This network acts as a temporary scaffold rather than a permanent material, because the body gradually remodels it after placement. The resulting balance between initial support and later breakdown allows damaged tissue to receive localized structural assistance during repair.
The fibrin network can remain positioned at the treatment site while supporting therapeutic cells or molecules placed within the gel. Its three-dimensional structure helps keep these payloads localized instead of relying only on systemic administration. This site-specific retention may support local healing or treatment while reducing the need for repeated systemic delivery.
Biocompatibility allows the fibrin-based matrix to function in damaged or diseased tissue, while biodegradability permits its gradual removal as the body remodels the implant. These properties are important because the material is intended to provide temporary support, not persist indefinitely. Together, they connect the implant's initial role as a scaffold with longer-term tissue repair.
A general workflow includes preparing the fibrin-based components, allowing thrombin to convert fibrinogen into a gel, shaping or loading the material as needed, and placing it into the target tissue. The implant can carry therapeutic cells or molecules before placement. The specific workflow therefore depends on whether the goal is repair, cell delivery, or localized treatment.
In wound management, the gel can be placed at a damaged site to provide a temporary matrix that supports local healing. Its ability to remain at the treatment area makes it relevant when localized support is preferred. The same implantation approach also provides a platform for regenerative research, where investigators examine tissue repair within a biodegradable scaffold.
Tissue engineering studies use the gel as a temporary scaffold that can be shaped for a damaged site and loaded with therapeutic cells. Controlled drug delivery studies instead take advantage of its ability to hold molecules locally and reduce dependence on repeated systemic administration. These applications evaluate both the material's placement at the target site and its gradual remodeling.